Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by DJDawg on Mar 06, 2023 11:09am

selling

Unfortunately TLT has such a terrible track record for oscillating in price that most people know that this happens regularly. The key is that it happens whenever there is an information gap:

- in the past month there was the mild anticipaton of ASCO and the return of RDW. That held some back from selling in case of good PR from those.

Now we are back to an information gap where no one as any idea if anything is going to happen for a while.

- RDW CEO return is unknown
- AUA is a bit further away and everyone is assuming that it will be similar data to ASCO ( I disagree. Suspect AUA will include the newest data set)
- no one know the money situation
- no info about any concrete effort on the JV side of things.
- nothing concrete on IND for the IV version of TLD-1433.
- rumours about yet another PP.

This is the perfect info void for the usual price run down.

Note to RDW (who follows this board daily) any information clarity is appreciated.

On the plus side, if there is any surprise good PR in the next few weeks, every single seller today will be trying to get back in and may not be able to do so easily. But who knows, TLT is a tough stock to hold and believe in.
Comment by Sosak1 on Mar 06, 2023 11:33am
You are absolutely correct on this. People forget so fast about an excellente results from last company report.. Numbers are great.
Comment by Eoganacht on Mar 06, 2023 12:33pm
I agree Sosak1. The most important fact to keep in mind is how well the trial is going. Adstiladrin got FDA approval in December based on a CR rate of 23.5% at 12 months. Dr. Kulkarni just reported a CR rate of 28% at 15 months for 29 evaluable patients. And that percentage should improve, because: The 29 patients include 5 who were improperly removed from the trial. 3 more who received zero ...more  
Comment by N0taP00p on Mar 06, 2023 12:14pm
Well said, DjDawg.   Vacuum has a tendency to suck in whatever gossip is floating out there.  And therein lies our problem.  The money situation and FDA submission timeline is the most critical info gap to fill.  Given thw very long time this stock has been stuck in a rut, we need a catalyst soon.  Hope it's coming. But not via another cheap PP. 
Comment by Legit62 on Mar 06, 2023 12:26pm
Its coming soon, we have enough money till the fall, by then we should be in jv talks, patience, this is just another buying op IMO
Comment by FGPstock on Mar 06, 2023 12:29pm
there are over 1.1M shares traded today between exchanges on the CAD side, another 500k+ on the US side. leads me to believe a financing NR is coming out tomorrow.
Comment by N0taP00p on Mar 06, 2023 1:58pm
Very likey possibility. The market always seems to know before retail folks
Comment by Pandora on Mar 06, 2023 10:58pm
[url=https://money.tmx.com/en/quote/TLT:CC]https://money.tmx.com/en/quote/TLT:CC[/url]
Comment by Pandora on Mar 06, 2023 11:04pm
Sometimes the SH link process works and sometimes it doesn't. You can highlight, right click and open in a new tab or you can copy and paste in your browser. https://money.tmx.com/en/quote/TLT:CC
Comment by riverrrow on Mar 06, 2023 1:04pm
If somebody has grow impatient and is willing to sell me shares at 30 cents I'm fine with that.  GLTA.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250